D

    DBV Technologies (DBVT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.82
    +0.28 (+2.07%)

    Market Cap: $850.93M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(20/36)
    Avg Surprise
    -30.46%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.15
    Range$-0.23 - $-0.10
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate Drift
    90d ago$-0.11+22.8%
    60d ago$-0.12+16.3%
    30d ago$-0.12+15.8%
    7d ago$-0.13+13.7%
    Current$-0.15
    Revenue Consensus
    $580830
    Range$0 - $874100
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.11
    Range$-0.28 - $0.05
    4 analysts
    Revenue Consensus
    $492690
    Range$-669390 - $1M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.11---
    Sep 26EST
    		-$-0.15---
    Jun 26
    Reported Jul 16
    		$-0.60$-0.12-400.00%Miss-122.2%
    Mar 26
    Reported Apr 30
    		$-0.09$-0.12+25.00%Beat+60.9%
    Dec 25
    Reported Mar 27
    		$-0.20$-0.19-5.73%Miss+6.2%
    Sep 25
    Reported Oct 28
    		$-0.21$-0.29+27.59%Beat+85.9%
    Jun 25
    Reported Jul 29
    		$-0.27$-0.16-68.75%Miss+82.8%
    Mar 25
    Reported Apr 30
    		$-0.23$-0.22-4.55%Miss+95.6%
    Dec 24
    Reported Mar 27
    		$-0.21$-0.21-1.24%Miss-265.9%
    Sep 24
    Reported Nov 6
    		$-1.49$-1.64+9.15%Beat+7.5%
    Jun 24
    Reported Jul 30
    		$-1.57$-2.65+40.75%Beat+33.5%
    Mar 24
    Reported May 7
    		$-5.20$-2.06-152.43%Miss-160.0%
    Dec 23
    Reported Mar 7
    		$-0.06N/A+74.74%Beat+86.8%
    Sep 23
    Reported Oct 31
    		$-1.61$-2.63+38.78%Beat+56.4%
    Jun 23
    Reported Jul 31
    		$-2.36$-2.27-3.96%Miss+30.8%
    Mar 23
    Reported May 4
    		$-2.00$-2.36+15.25%Beat-640.7%
    Dec 22
    Reported Mar 2
    		$-0.44$-0.17-158.82%Miss+88.4%
    Sep 22
    Reported Nov 3
    		$-3.69$-3.15-17.14%Miss-19.0%
    Jun 22
    Reported Aug 1
    		$-3.41$-3.03-12.54%Miss-30.7%
    Mar 22
    Reported May 2
    		$-0.27$-0.39+30.77%Beat+93.4%
    Dec 21
    Reported Mar 3
    		$-3.79N/A+57.65%Beat-28.5%
    Sep 21
    Reported Oct 26
    		$-3.10$-0.43-620.93%Miss-367.8%
    Jun 21
    Reported Aug 2
    		$-2.61$-4.50+42.00%Beat+65.7%
    Mar 21
    Reported May 3
    		$-4.08$-4.60+11.30%Beat-374.7%
    Dec 20
    Reported Mar 11
    		$-2.95$-1.22-141.80%Miss+71.6%
    Sep 20
    Reported Oct 30
    		$-0.66$-0.30-120.89%Miss-57.8%
    Jun 20
    Reported Jul 31
    		$-7.60$-9.40+19.15%Beat+6.2%
    Mar 20
    Reported Apr 30
    		$-0.86$0.00N/ABeat+43.8%
    Dec 19
    Reported Jan 29
    		$-10.40$-7.20-44.44%Miss-10.6%
    Sep 19
    Reported Sep 30
    		$-0.42$-0.47+10.64%Beat+61.3%
    Jun 19
    Reported Aug 1
    		$-8.10$-10.00+19.00%Beat+12.0%
    Mar 19
    Reported Apr 30
    		$-1.53$-1.21-26.32%Miss+83.7%
    Dec 18
    Reported Mar 5
    		$-9.40$-16.83+44.15%Beat+24.2%
    Sep 18
    Reported Oct 30
    		$-1.08$-0.94-15.37%Miss-
    Jun 18
    Reported Sep 7
    		$-9.20$-11.45+19.65%Beat-318.2%
    Dec 17
    Reported Mar 14
    		$-9.40$-17.60+46.59%Beat-
    Jun 17
    Reported Jul 28
    		$-12.40$-15.75+21.27%Beat-
    Mar 17
    Reported Apr 6
    		$0.00N/A+100.00%Beat-
    Dec 16
    Reported Mar 15
    		$-2.20$-4.00+45.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio-12.57EV/EBITDA-2.07x
    Price/FCF-5.90xFCF Yield-16.95%
    Profitability
    Profit Margin0.00%Operating Margin-7229.00%
    ROE-142.70%ROIC-100.99%
    Financial Health
    Debt/Equity0.09xInterest CoverageN/A
    Current Ratio3.72xQuick Ratio3.72x
    Trading Statistics
    Beta-0.24Avg Volume285.77K
    52-Week High$26.1852-Week Low$8.70

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.34
    SMA 20$14.19
    SMA 50$14.77
    SMA 200$18.14
    EMA 10$14.19
    EMA 20$14.26
    EMA 50$14.99
    EMA 200$16.22

    MACD

    Line: -0.15Signal: -0.17Hist: 0.01

    ADX

    ADX: 13.3+DI: 19.1-DI: 27.6

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down16.0
    PSAR$15.10

    Bollinger Bands

    Upper Band$15.00
    Lower Band$13.38
    %B Position1144%(Upper)
    Band Width0.27

    RSI (14-Day)

    Neutral
    44.5

    Momentum Oscillators

    Stoch %K28.9
    Stoch %D48.5
    Williams %R-78.0
    ROC (10d)-5.8%
    Momentum-0.85
    CCI (20d)-96.1
    MFI (14d)37.3

    Volatility Measures

    ATR (14d)$0.70(5.1%)
    StdDev (20d)0.41
    Hist Vol52.4%(High)

    Volume Flow

    VWAP$13.75
    OBV26.6M
    AD Line-2.5M
    CMF (20d)-0.043

    Volume Metrics

    Avg Vol (20d)284.8K
    Vol Ratio0.6x
    VWMA (20d)$14.06

    Pivot Points

    R3$15.06
    R2$14.72
    R1$14.13
    Pivot Point$13.79
    S1$13.20
    S2$12.86
    S3$12.27

    Advanced Oscillators

    TSI-5.98
    Ultimate Osc49.0
    KST-14.88

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$511,000$0$1.07M$1.16M$1.41M$8.88M$2.40M
    Cost of RevenueN/A$4.22M$4.28M$4.28M$4.62M$4.48MN/A$3.11M$4.15M$4.46M$-13,574,000$455,635
    Gross ProfitN/A$-4,215,266$-4,279,827$-4,281,868$-4,619,486$511,000N/A$1.07M$-4,152,110$1.41M$8.88M$-455,635
    Operating Expenses$51.30M$47.90M$45.05M$32.61M$38.49M$26.62M$23.86M$31.40M$30.82M$29.96M$20.80M$20.10M
    R&D$31.20M$33.40M$32.89M$26.82M$31.60M$21.48M$18.90M$23.66M$23.62M$21.40M$12.78M$15.86M
    SG&A$14.60M$13.40M$11.35M$5.81M$8.64M$4.31M$4.40M$6.05M$7.20M$6.20M$7.20M$4.24M
    Operating Income$-51,300,000$-47,900,000$-45,051,000$-36,887,187$-43,111,495$-26,618,000$-23,861,000$-30,328,000$-34,970,238$-28,558,000$-11,920,000$-20,557,333
    Interest Income$0$0$0$0$0$0$0$0$0$1.26M$0$1.50M
    Interest Expense$0$0$0$0$656,165$461,344$0$113,000$0$0$22.75M$0
    Income Before Tax$-51,300,000$-47,400,000$-44,455,000$-35,778,142$-43,767,660$-27,832,562$-23,008,000$-30,442,000$-34,244,918$-27,297,000$-11,180,000$-17,880,201
    Income Tax Expense$-900,000$200,000$374,000$-2,761,660$-1,364,986$-753,562$7,000$-1,075,059$-1,159,913$48,000$6,000$-1,230,613
    Net Income$-50,400,000$-47,600,000$-44,829,000$-33,016,481$-42,402,674$-27,079,000$-23,015,000$-30,442,000$-33,085,005$-27,345,000$-11,186,000$-16,649,588
    EBITDA$-51,300,000$-45,900,000$-43,594,000$-31,497,269$-38,492,008$-25,038,000$-22,797,000$-28,642,000$-30,092,808$-26,192,000$-8,630,500$-17,424,566
    EBIT$-50,600,000$-47,900,000$-45,048,000$-35,779,137$-43,111,494$-26,617,000$-23,435,000$-30,330,000$-34,244,918$-28,559,000$-11,921,000$-17,880,201
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DBVT

    News

    Arrowstreet Capital discloses net short position in DBV Technologies

    Arrowstreet Capital has disclosed a 0.71% net short position in DBV Technologies. This news brief was generated by artificial intelligence based on information published by DBV Technologies SA. The content is for informational purposes only and not financial advice.

    Bitget•8/20/26•
    Neutral

    JPMorgan cuts DBV Technologies stake below 10% to 8.67%

    JPMorgan Chase initially increased its stake in DBV Technologies above 10% on August 7th, holding 11.15% of shares, but then reduced it to 8.67% on August 10th. This fluctuation was primarily due to changes in holdings related to prime brokerage custody and financing. JPMorgan stated it has no intention of seeking control or board representation in DBV Technologies.

    Bitget•8/18/26•
    Somewhat-Bearish

    DBV Technologies (NASDAQ:DBVT) Shares Up 6.2% - Here's Why

    DBV Technologies (NASDAQ:DBVT) saw its shares increase by 6.2% during midday trading, despite a significant drop in trading volume and a recent quarterly loss that missed analyst estimates. The company has a "Moderate Buy" consensus rating from analysts, though recent reports include both buy and sell downgrades. Institutional investors have made various adjustments to their holdings in the biopharmaceutical firm.

    MarketBeat•8/17/26•
    Neutral

    MPM BioImpact LLC discloses 6.2% stake in DBV Technologies (DBVT)

    MPM BioImpact LLC has disclosed an amended Schedule 13G filing, reporting a beneficial ownership of 18,331,420 Ordinary Shares in DBV Technologies S.A. This represents a 6.2% stake in the company, with MPM BioImpact LLC holding sole voting and dispositive power over these shares. The reported stake is held through American Depositary Shares (ADSs), where each ADS corresponds to five Ordinary Shares.

    Stock Titan•8/14/26•
    Neutral

    DBV technologies S.A. (ADR) (DBV1.SG) balance sheet

    This article provides the balance sheet for DBV technologies S.A. (ADR) (DBV1.SG) as of December 31 for the years 2022 through 2025. It details key financial figures such as total assets, liabilities, equity, and share information, sourced from Yahoo Finance. The data is presented in thousands of USD, offering a snapshot of the company's financial health over the specified period.

    Yahoo Finance UK•8/11/26•
    Neutral

    Frequently Asked Questions About DBVT

    Does DBVT pay dividends?
    DBV Technologies (DBVT) does not currently pay a regular dividend.
    What is DBVT's market cap?
    DBV Technologies (DBVT) has a market capitalization of $850.93M with a current stock price of $13.82.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In